HCW Biologics (HCWB) Short Interest Ratio & Short Volume $0.40 0.00 (-0.20%) (As of 12/24/2024 05:19 PM ET) Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends HCW Biologics Short Interest DataHCW Biologics (HCWB) has a short interest of 128,900 shares, representing 0.65% of the float (the number of shares available for trading by the public). This marks a -10.92% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 2.42 million shares to cover all short positions.Current Short Interest128,900 sharesPrevious Short Interest144,700 sharesChange Vs. Previous Month-10.92%Dollar Volume Sold Short$60,840.80Short Interest Ratio0.0 Days to CoverLast Record DateNovember 30, 2024Outstanding Shares37,823,000 sharesFloat Size19,750,000 sharesShort Percent of Float0.65%Today's Trading Volume119,470 sharesAverage Trading Volume2,422,909 sharesToday's Volume Vs. Average5% Short Selling HCW Biologics? Sign up to receive the latest short interest report for HCW Biologics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartHCWB Short Interest Over TimeHCWB Days to Cover Over TimeHCWB Percentage of Float Shorted Over Time Ad Crypto 101 MediaTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW HCW Biologics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/2024128,900 shares $60,840.80 -10.9%0.7%0 $0.47 11/15/2024144,700 shares $42,628.62 +1,686.4%0.7%0 $0.29 10/31/20248,100 shares $3,491.10 -67.5%0.0%0.3 $0.43 10/15/202424,900 shares $13,944.00 -11.4%0.1%1.1 $0.56 9/30/202428,100 shares $15,157.14 +119.5%0.2%1.4 $0.54 9/15/202412,800 shares $7,808.00 +212.2%0.1%0.5 $0.61 Get the Latest News and Ratings for HCWB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for HCW Biologics and its competitors with MarketBeat's FREE daily newsletter. 8/31/20244,100 shares $1,890.10 -65.0%0.0%0.2 $0.46 8/15/202411,700 shares $5,861.70 +69.6%0.1%0.7 $0.50 7/31/20246,900 shares $4,165.53 -4.2%0.0%0.3 $0.60 7/15/20247,200 shares $5,040.00 -21.7%0.0%0.4 $0.70 6/30/20249,200 shares $5,952.40 +70.4%0.1%0.4 $0.65 6/15/20245,400 shares $6,048.00 +350.0%0.0%0.3 $1.12 5/31/20241,200 shares $1,308.00 -7.7%0.0%0.1 $1.09 5/15/20241,300 shares $1,508.00 -84.9%0.0%0.1 $1.16 4/30/20248,600 shares $12,040.00 +13.2%0.1%0.5 $1.40 4/15/20247,600 shares $12,312.00 -52.2%0.1%0.5 $1.62 3/31/202415,900 shares $27,825.00 -27.7%0.1%1 $1.75 3/15/202422,000 shares $33,660.00 -8.3%0.1%1.3 $1.53 2/29/202424,000 shares $35,280.00 +445.5%0.2%1.7 $1.47 2/15/20244,400 shares $5,030.08 +2.3%0.0%0.4 $1.14 1/31/20244,300 shares $4,945.00 -39.4%0.0%0.2 $1.15 1/15/20247,100 shares $8,378.00 -4.1%0.0%0.4 $1.18 12/31/20237,400 shares $9,065.00 -38.8%0.0%0.4 $1.23 12/15/202312,100 shares $13,431.00 -40.7%0.1%0.8 $1.11 11/30/202320,400 shares $22,032.00 -4.7%0.1%1.4 $1.08 11/15/202321,400 shares $19,688.00 +170.9%0.1%1.6 $0.92 10/31/20237,900 shares $13,272.00 -16.8%0.0%0.6 $1.68 10/15/20239,500 shares $17,290.00 -10.4%0.1%1.3 $1.82 9/30/202310,600 shares $20,140.00 -53.1%0.1%1.3 $1.90 9/15/202322,600 shares $45,426.00 +5.6%0.1%2.5 $2.01 8/31/202321,400 shares $38,734.00 -14.4%0.1%1.9 $1.81 8/15/202325,000 shares $52,000.00 +7.8%0.1%1.4 $2.08 7/31/202323,200 shares $47,328.00 -13.4%0.1%1.2 $2.04 7/15/202326,800 shares $56,816.00 -23.7%0.2%1.4 $2.12 6/30/202335,100 shares $76,167.00 +44.4%0.2%1.8 $2.17 6/15/202324,300 shares $51,759.00 +86.9%0.1%1.2 $2.13 5/31/202313,000 shares $19,110.00 -13.3%0.1%0.7 $1.47 5/15/202315,000 shares $22,051.50 -45.3%0.1%1 $1.47 4/30/202327,400 shares $39,146.38 -0.7%0.2%1.8 $1.43 4/15/202327,600 shares $41,400.00 +10.8%0.2%1.5 $1.50Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong (Ad)Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.Click here to watch this demo and decide for yourself. 3/31/202324,900 shares $34,884.90 +11.7%0.1%1.2 $1.40 3/15/202322,300 shares $30,105.00 -20.6%0.1%1 $1.35 2/28/202328,100 shares $50,580.00 +53.6%0.2%1.3 $1.80 2/15/202318,300 shares $34,587.00 +140.8%0.1%0.8 $1.89 1/31/20237,600 shares $14,744.00 -68.3%0.0%0.4 $1.94 1/15/202324,000 shares $51,600.00 +31.2%0.2%1.2 $2.15 12/30/202218,300 shares $35,040.84 +19.6%0.1%1.1 $1.91 12/15/202215,300 shares $30,600.00 -41.6%0.1%0.8 $2.00 11/30/202226,200 shares $55,302.96 +84.5%0.2%1.2 $2.11 11/15/202214,200 shares $31,240.00 +23.5%0.1%0.6 $2.20 10/31/202211,500 shares $25,760.00 -45.2%0.1%0.5 $2.24 10/15/202221,000 shares $46,830.00 -58.7%0.1%0.9 $2.23 9/30/202250,900 shares $116,561.00 +216.2%0.3%2.4 $2.29 9/15/202216,100 shares $39,284.00 +35.3%0.1%0.9 $2.44 8/31/202211,900 shares $30,542.54 -7.8%0.1%0.7 $2.57 8/15/202212,900 shares $28,767.00 -30.7%0.1%1 $2.23 7/31/202218,600 shares $44,454.00 +78.9%0.1%1.4 $2.39 7/15/202210,400 shares $24,232.00 -38.1%0.1%0.8 $2.33 6/30/202216,800 shares $36,960.00 +24.4%0.1%0.9 $2.20 6/15/202213,500 shares $32,265.00 -9.4%0.1%0.5 $2.39 5/31/202214,900 shares $30,992.00 -54.6%0.1%0.5 $2.08 5/15/202232,800 shares $64,616.00 +9.0%0.2%1.1 $1.97 4/30/202230,100 shares $70,434.00 -32.5%0.2%0.9 $2.34 4/15/202244,600 shares $121,312.00 -3.5%0.3%0.9 $2.72 3/31/202246,200 shares $126,126.00 -11.0%0.3%0.7 $2.73 3/15/202251,900 shares $106,914.00 +19.6%0.4%0.6 $2.06 2/28/202243,400 shares $95,046.00 -32.4%0.3%0.4 $2.19 2/15/202264,200 shares $150,870.00 -18.5%0.5%0.6 $2.35 1/31/202278,800 shares $168,632.00 -39.3%0.6%0.5 $2.14 1/15/2022129,800 shares $288,156.00 +5.3%1.1%0 $2.22 12/31/2021123,300 shares $286,056.00 +35.5%1.0%0 $2.32 12/15/202191,000 shares $249,340.00 -3.1%0.7%0 $2.74 11/30/202193,900 shares $269,493.00 -0.2%0.8%0 $2.87 11/15/202194,100 shares $278,536.00 -39.5%0.8%0 $2.96 10/29/2021155,400 shares $694,638.00 +60.0%1.3%0.1 $4.47 10/15/202197,100 shares $254,402.00 No Change0.8%0.6 $2.62 9/30/202197,100 shares $309,749.00 +13.0%0.8%0.7 $3.19 9/15/202185,900 shares $325,561.00 +30.2%0.7%0.6 $3.79 8/31/202166,000 shares $262,020.00 +1,366.7%0.8%0.4 $3.97 8/13/20214,500 shares $23,040.00 No Change0.1%0 $5.12 HCWB Short Interest - Frequently Asked Questions What is HCW Biologics' current short interest? Short interest is the volume of HCW Biologics shares that have been sold short but have not yet been covered or closed out. As of November 30th, traders have sold 128,900 shares of HCWB short. 0.65% of HCW Biologics' shares are currently sold short. Learn More on HCW Biologics' current short interest. What is a good short interest percentage for HCW Biologics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.65% of HCW Biologics' floating shares are currently sold short. Is HCW Biologics' short interest increasing or decreasing? HCW Biologics saw a drop in short interest in the month of November. As of November 30th, there was short interest totaling 128,900 shares, a drop of 10.9% from the previous total of 144,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is HCW Biologics' float size? HCW Biologics currently has issued a total of 37,823,000 shares. Some of HCW Biologics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. HCW Biologics currently has a public float of 19,750,000 shares. How does HCW Biologics' short interest compare to its competitors? 0.65% of HCW Biologics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to HCW Biologics: Immix Biopharma, Inc. (2.87%), IO Biotech, Inc. (0.10%), Eliem Therapeutics, Inc. (2.22%), Repare Therapeutics Inc. (2.00%), Kronos Bio, Inc. (1.30%), Invivyd, Inc. (6.60%), Mural Oncology plc (3.07%), Galectin Therapeutics Inc. (13.54%), Connect Biopharma Holdings Limited (0.11%), Reviva Pharmaceuticals Holdings, Inc. (18.42%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short HCW Biologics stock? Short selling HCWB is an investing strategy that aims to generate trading profit from HCW Biologics as its price is falling. HCWB shares are trading down $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against HCW Biologics? A short squeeze for HCW Biologics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of HCWB, which in turn drives the price of the stock up even further. How often is HCW Biologics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HCWB, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies Immix Biopharma Short Squeeze IO Biotech Short Squeeze Eliem Therapeutics Short Squeeze Repare Therapeutics Short Squeeze Kronos Bio Short Squeeze Invivyd Short Squeeze Mural Oncology Short Squeeze Galectin Therapeutics Short Squeeze Connect Biopharma Short Squeeze Reviva Pharmaceuticals Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:HCWB) was last updated on 12/25/2024 by MarketBeat.com Staff From Our PartnersWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Behind the Markets | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HCW Biologics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share HCW Biologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
